← Leaderboards
Herta Huey-An Chao
Va Connecticut Healthcare System
$2,072,329
Attributed
$2,072,329
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $505.7K · FY2009–25$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,072,329 · 2
VA$0 · 1
By mechanism
R01$1,941,929 · 1
R03$130,400 · 1
I01$0 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Quality Of Life”
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Gregory H Reaman · National Childhood Cancer Foundation$264,644,476
- David R. Weir · University Of Michigan At Ann Arbor$263,050,576
- Richard K. Wilson · Washington University$198,912,538
Research focus
Quality Of LifeNeurocognitive TestCognitive FunctionCognitiveImpaired CognitionParticipantCancer PatientMalignant Neoplasm Of ProstateCancer TherapyBrainCognitionBrain ImagingNeuropsychological TestsPilot ProjectsFutureGray MatterMetastatic Prostate CancerElderlyAnxietyAndrogen Deprivation TherapyEvaluationMagnetic Resonance ImagingHormonalNeoplasm Metastasis
Grant awards (14)
Effects of ADT on motivation and emotion function in prostate cancer patients: longitudinal imaging and prediction$0
I01 · FY2025 · VA · contact PI
Effects of ADT on motivation and emotion function in prostate cancer patients: longitudinal imaging and prediction$0
I01 · FY2024 · VA · contact PI
Neurocognitive Changes from Long-Term Androgen Deprivation Therapy in Prostate Cancer Patients$323,336
R01 · FY2023 · CA · contact PI
Neurocognitive Changes from Long-Term Androgen Deprivation Therapy in Prostate Cancer Patients$382,415
R01 · FY2022 · CA · contact PI
Neurocognitive Changes from Long-Term Androgen Deprivation Therapy in Prostate Cancer Patients$375,192
R01 · FY2021 · CA · contact PI
ADT and brain dysfunction in prostate ca: the effects of age & neural plasticity$0
I01 · FY2021 · VA · contact PI
Neurocognitive Changes from Long-Term Androgen Deprivation Therapy in Prostate Cancer Patients$1
R01 · FY2020 · CA · contact PI
Neurocognitive Changes from Long-Term Androgen Deprivation Therapy in Prostate Cancer Patients$505,673
R01 · FY2019 · CA · contact PI
ADT and brain dysfunction in prostate ca: the effects of age & neural plasticity$0
I01 · FY2019 · VA · contact PI
Neurocognitive Changes from Long-Term Androgen Deprivation Therapy in Prostate Cancer Patients$355,312
R01 · FY2018 · CA · contact PI
ADT and brain dysfunction in prostate ca: the effects of age & neural plasticity$0
I01 · FY2018 · VA · contact PI
ADT and brain dysfunction in prostate ca: the effects of age & neural plasticity$0
I01 · FY2017 · VA · contact PI
Imaging the effects of androgen deprivation therapy on cognitive functions in pat$65,200
R03 · FY2010 · CA · contact PI
Imaging the effects of androgen deprivation therapy on cognitive functions in pat$65,200
R03 · FY2009 · CA · contact PI